2015
DOI: 10.1515/labmed-2015-0072
|View full text |Cite
|
Sign up to set email alerts
|

Presepsin (sCD14-ST) as a biomarker of sepsis in clinical practice and in emergency department: a mini review

Abstract: Presepsin is a 13-kDa protein that is a fragment of CD14 with truncated N-terminal, the receptor for lipopolysaccharide (LPS)/LPS-binding protein complexes. It is a novel marker being sought in many diseases such as sepsis, kidney failure, disseminated intravascular coagulation, etc. In this review, we aimed to clarify its utility in critical diseases and availability in critical care settings such as emergency departments and intensive care units.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 37 publications
0
1
0
Order By: Relevance
“…Procalcitonin levels do not increase or increase only slightly in non-bacterial inflammatory syndromes. Procalcitonin also provides prognostic information and risk stratification assessment in the emergency unit 17 . In our study, we determined that plasma levels of these two biomarkers elevate in both sepsis and severe sepsis.…”
Section: Resultsmentioning
confidence: 99%
“…Procalcitonin levels do not increase or increase only slightly in non-bacterial inflammatory syndromes. Procalcitonin also provides prognostic information and risk stratification assessment in the emergency unit 17 . In our study, we determined that plasma levels of these two biomarkers elevate in both sepsis and severe sepsis.…”
Section: Resultsmentioning
confidence: 99%